Fluticasone furoate for the treatment of childhood asthma

Explore this paper's citation graph

Summary

The introduction of once-daily inhaled fluticasone furoate, either alone or in combination with the long-acting β-agonist, vilanterol, simplifies chronic asthma therapy and may improve adherence and as a result, outcomes in this vulnerable population.

Type
review
Published
2015-07-04
Cited by
2
References
51

Keywords

Fluticasone propionate, Medicine, Asthma, Pediatrics, Inhaled corticosteroids

References

Cited by

Related papers